| Literature DB >> 28289028 |
Matthew B Lohse1,2, Megha Gulati3, Ashley Valle Arevalo3,4, Adam Fishburn3, Alexander D Johnson1,5, Clarissa J Nobile6.
Abstract
Candida albicans biofilms have a significant medical impact due to their rapid growth on implanted medical devices, their resistance to antifungal drugs, and their ability to seed disseminated infections. Biofilm assays performed in vitro allow for rapid, high-throughput screening of gene deletion libraries or antifungal compounds and typically serve as precursors to in vivo studies. Here, we compile and discuss the protocols for several recently published C. albicansin vitro biofilm assays. We also describe improved versions of these protocols as well as novel in vitro assays. Finally, we consider some of the advantages and disadvantages of these different types of assays.Entities:
Keywords: Candida albicans; biofilm; biofilm methods; biofilm protocols; biofilm screens; in vitro biofilm assays
Mesh:
Substances:
Year: 2017 PMID: 28289028 PMCID: PMC5404589 DOI: 10.1128/AAC.02749-16
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191